IFG Advisory’s Thermo Fisher Scientific TMO Stock Holding History

IFG Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-426	Closed	-$247K	–	826
2025 Q4	$247K	Buy	+426	New	+$241K	0.01%	683
2025 Q3	–	Sell	-497	Closed	-$202K	–	795
2025 Q2	$202K	Buy	497 +73	+17%	+$30.5K	0.01%	720
2025 Q1	$211K	Buy	424 +5	+1%	+$2.71K	0.01%	646
2024 Q4	$218K	Buy	+419	New	+$230K	0.01%	627
2024 Q3	–	Sell	-397	Closed	-$220K	–	597
2024 Q2	$220K	Buy	+397	New	+$227K	0.01%	569
2024 Q1	–	Sell	-414	Closed	-$220K	–	560
2023 Q4	$220K	Buy	+414	New	+$200K	0.02%	540
2023 Q2	–	Sell	-489	Closed	-$282K	–	480
2023 Q1	$282K	Buy	489 +55	+13%	+$31K	0.03%	420
2022 Q4	$239K	Sell	434 -384	-47%	-$203K	0.02%	433
2022 Q3	$414K	Buy	818 +301	+58%	+$168K	0.04%	349
2022 Q2	$281K	Sell	517 -18	-3%	-$9.91K	0.03%	387
2022 Q1	$316K	Sell	535 -96	-15%	-$55.1K	0.03%	387
2021 Q4	$421K	Buy	631 +18	+3%	+$11.2K	0.04%	336
2021 Q3	$350K	Buy	613 +16	+3%	+$8.78K	0.04%	365
2021 Q2	$301K	Buy	597 +52	+10%	+$24.5K	0.03%	392
2021 Q1	$248K	Sell	545 -34	-6%	-$16.2K	0.03%	428
2020 Q4	$269K	Buy	579 +103	+22%	+$48.3K	0.04%	375
2020 Q3	$210K	Buy	+476	New	+$197K	0.03%	389

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IFG Advisory's TMO Position: Q1 2026 in Review

IFG Advisory sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 426 shares — an estimated $247K sold.

IFG Advisory first reported a position in TMO in Q3 2020 and held it in 17 quarters. The position peaked at $421K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

IFG Advisory reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
IFG Advisory sold 426 Thermo Fisher Scientific shares in Q1 2026, an estimated $247K.
IFG Advisory first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 17 quarters.
IFG Advisory's Thermo Fisher Scientific position peaked at $421K in Q4 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.